Emerging drug development technologies targeting ubiquitination for cancer therapeutics

Development of effective cancer therapeutic strategies relies on our ability to interfere with cellular processes that are dysregulated in tumors. Given the essential role of the ubiquitin proteasome system (UPS) in regulating a myriad of cellular processes, it is not surprising that malfunction of...

Descripción completa

Detalles Bibliográficos
Autores principales: Veggiani, Gianluca, Gerpe, María Carla Rosales, Sidhu, Sachdev S., Zhang, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7112620/
https://www.ncbi.nlm.nih.gov/pubmed/30851297
http://dx.doi.org/10.1016/j.pharmthera.2019.03.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7112620/
https://www.ncbi.nlm.nih.gov/pubmed/30851297
http://dx.doi.org/10.1016/j.pharmthera.2019.03.003

Ejemplares similares